Hovedundersøgelsen viste, at vaccinen indeholdt 3, 75 mikrogram hæmagglutinin, og at adjuvanset udløste en antistofrespons, der opfyldte disse kriterier.
The main study showed that the vaccine containing 3.75 micrograms of haemagglutinin and the adjuvant produced an antibody response that met these criteria.